LV10253B - Indenoindole compounds ii - Google Patents

Indenoindole compounds ii

Info

Publication number
LV10253B
LV10253B LVP-93-568A LV930568A LV10253B LV 10253 B LV10253 B LV 10253B LV 930568 A LV930568 A LV 930568A LV 10253 B LV10253 B LV 10253B
Authority
LV
Latvia
Prior art keywords
lower alkyl
hydrogen
group
cor
alkyl group
Prior art date
Application number
LVP-93-568A
Other languages
English (en)
Other versions
LV10253A (lv
Inventor
Malcolm Sainsbury
Howard G Shertzer
Original Assignee
Univ Bath
Univ Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bath, Univ Cincinnati filed Critical Univ Bath
Publication of LV10253A publication Critical patent/LV10253A/xx
Publication of LV10253B publication Critical patent/LV10253B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
LVP-93-568A 1989-06-22 1993-06-14 Indenoindole compounds ii LV10253B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8902274A SE8902274D0 (sv) 1989-06-22 1989-06-22 Indenoidole compounds ii
PCT/GB1990/000949 WO1990015799A1 (en) 1989-06-22 1990-06-20 Indenoindole compounds ii

Publications (2)

Publication Number Publication Date
LV10253A LV10253A (lv) 1994-10-20
LV10253B true LV10253B (en) 1995-04-20

Family

ID=20376370

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-568A LV10253B (en) 1989-06-22 1993-06-14 Indenoindole compounds ii

Country Status (34)

Country Link
EP (1) EP0409410B1 (xx)
JP (1) JP3064411B2 (xx)
KR (1) KR920702679A (xx)
CN (1) CN1033029C (xx)
AT (1) ATE135688T1 (xx)
BG (1) BG60317B2 (xx)
CA (1) CA2060897A1 (xx)
DD (1) DD297960A5 (xx)
DE (1) DE69025998T2 (xx)
DK (1) DK0409410T3 (xx)
DZ (1) DZ1428A1 (xx)
ES (1) ES2084660T3 (xx)
FI (1) FI100800B (xx)
GR (1) GR3019779T3 (xx)
HR (1) HRP920903B1 (xx)
HU (1) HUT59097A (xx)
IE (1) IE74682B1 (xx)
IL (1) IL94830A (xx)
IS (1) IS3590A7 (xx)
LT (1) LT3675B (xx)
LV (1) LV10253B (xx)
MX (1) MX21244A (xx)
MY (1) MY107311A (xx)
NO (1) NO177932C (xx)
NZ (1) NZ234175A (xx)
PL (1) PL167761B1 (xx)
PT (1) PT94468B (xx)
RO (1) RO111573B1 (xx)
RU (1) RU2104270C1 (xx)
SE (1) SE8902274D0 (xx)
SI (1) SI9011223B (xx)
WO (1) WO1990015799A1 (xx)
YU (1) YU122390A (xx)
ZA (1) ZA904827B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1061962A (zh) * 1990-10-16 1992-06-17 巴斯大学 茚并吲哚化合物
JPH0656669A (ja) * 1992-06-11 1994-03-01 Asahi Breweries Ltd 活性酸素消去作用を持つプテリン誘導体製剤
SE9302431D0 (sv) * 1993-07-16 1993-07-16 Ab Astra Use of indenoindole compounds
CA2128283A1 (fr) * 1993-07-20 1995-01-21 Paul Caubere (thia)cycloalkyl¬b|indoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2350590A1 (en) * 1998-12-04 2000-06-15 John A. Butera Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
US6288099B1 (en) 1998-12-04 2001-09-11 American Home Products Corporation Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
FR2826009B1 (fr) * 2001-06-13 2003-08-15 Servier Lab Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2612442A1 (en) 2005-07-14 2007-01-18 Irm Llc Heterotetracyclic compounds as tpo mimetics
DE102006047231B4 (de) * 2006-10-04 2009-02-12 Hemmerling, Hans-Jörg, Dr. Substituierte Indeno[1,2-b]indolderivate als neue Hemmstoffe der Protein Kinase CK2 und ihre Verwendung als Tumor Therapeutika, Cytostatika und Diagnostika
US9464067B2 (en) * 2011-06-16 2016-10-11 Katholieke Universiteit Leuven K.U. Leuven R & D Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
CN105121433B (zh) 2012-12-14 2018-01-23 韩国化学研究院 抗病毒化合物、其药学上可接受的盐或光学异构体、用于制备它们的方法以及包含它们作为有效成分的用于预防或治疗病毒性疾病的药物组合物

Also Published As

Publication number Publication date
ATE135688T1 (de) 1996-04-15
SI9011223A (en) 1997-10-31
BG60317B2 (bg) 1994-07-25
WO1990015799A1 (en) 1990-12-27
SI9011223B (sl) 1998-08-31
RO111573B1 (ro) 1996-11-29
HRP920903A2 (hr) 1994-04-30
KR920702679A (ko) 1992-10-06
MX21244A (es) 1994-03-31
NO177932B (no) 1995-09-11
CN1033029C (zh) 1996-10-16
DZ1428A1 (fr) 2004-09-13
GR3019779T3 (en) 1996-07-31
SE8902274D0 (sv) 1989-06-22
DE69025998T2 (de) 1996-08-08
PL285752A1 (en) 1991-03-11
NO915049D0 (no) 1991-12-20
ZA904827B (en) 1991-04-24
AU644084B2 (en) 1993-12-02
NZ234175A (en) 1992-12-23
HRP920903B1 (en) 1998-06-30
DK0409410T3 (da) 1996-04-29
IS3590A7 (is) 1990-12-23
YU122390A (sh) 1992-09-07
JP3064411B2 (ja) 2000-07-12
IE74682B1 (en) 1997-07-30
DD297960A5 (de) 1992-01-30
PL167761B1 (pl) 1995-10-31
HUT59097A (en) 1992-04-28
HU904825D0 (en) 1992-03-30
IE902247L (en) 1990-12-22
DE69025998D1 (de) 1996-04-25
PT94468A (pt) 1991-02-08
CN1051554A (zh) 1991-05-22
MY107311A (en) 1995-11-30
LTIP912A (en) 1995-03-27
NO177932C (no) 1995-12-20
RU2104270C1 (ru) 1998-02-10
AU5836990A (en) 1991-01-08
EP0409410B1 (en) 1996-03-20
CA2060897A1 (en) 1990-12-23
IE902247A1 (en) 1991-01-16
ES2084660T3 (es) 1996-05-16
NO915049L (no) 1992-02-21
FI915999A0 (fi) 1991-12-19
PT94468B (pt) 1997-12-31
LT3675B (en) 1996-01-25
JPH04505923A (ja) 1992-10-15
FI100800B (fi) 1998-02-27
LV10253A (lv) 1994-10-20
IL94830A0 (en) 1991-04-15
IL94830A (en) 1996-07-23
EP0409410A1 (en) 1991-01-23

Similar Documents

Publication Publication Date Title
ZA847650B (en) 1-methylamino-cyclopropane-1-carboxylic acid derivatives
EP0163599A3 (en) Pyrimidopyrimidine derivatives, processes for producing them, pharmaceutical compositions containing them and their use as anti-allergic agents
GR3004139T3 (xx)
LV10253B (en) Indenoindole compounds ii
IE851205L (en) Beta-carbolines
ZA956327B (en) Novel pyrrolocarbazoles
SE8902273D0 (sv) Indenoindole compounds i
ZA853717B (en) Beta-carboline-3-carboxylic acid derivatives,method of preparing the same and their use
ZA895623B (en) Tetracyclic antidepressants
JO1676B1 (en) Extra compounds indinol II
EP0470832A3 (en) Biphenyl 5, 5'-bis-alkanoic acid derivatives, their production and use thereof
AU566243B2 (en) Optically active imidazolylpropanols
AU4370489A (en) The use of oxidized polyamines, especially nn'-bis-(3- propionaldehyde)-1-4-diaminobutane (sperminedialdehyde) as immunosuppressive agents
GB2021587A (en) Benzoquinolizines